Y. Chikata

发表

Long-term impact of high-sensitivity C-reactive protein in patients with intermittent claudication due to peripheral artery disease following endovascular treatment

H. Daida, T. Minamino, H. Iwata, 2021, Heart and Vessels.

Enhanced monocyte migratory activity in the pathogenesis of structural remodeling in atrial fibrillation

H. Daida, T. Minamino, H. Iwata, 2020, PloS one.

Combined impacts of low apolipoprotein A-I levels and reduced renal function on long-term prognosis in patients with coronary artery disease undergoing percutaneous coronary intervention.

H. Daida, T. Minamino, T. Dohi, 2022, Clinica chimica acta; international journal of clinical chemistry.

Predictors of discordance between fractional flow reserve and resting full-cycle ratio in patients with coronary artery disease: Evidence from clinical practice.

H. Daida, T. Minamino, H. Iwata, 2020, Journal of cardiology.

Elevated Heart Rate in Combination with Elevated Blood Pressure Predicts Lower Cardiovascular Mortality in Acute Decompensated Heart Failure.

Kenji Inoue, T. Miyazaki, H. Daida, 2020, International heart journal.

Relationship between coronary high-intensity plaques on T1-weighted imaging by cardiovascular magnetic resonance and vulnerable plaque features by near-infrared spectroscopy and intravascular ultrasound: a prospective cohort study

Debiao Li, M. Hiki, H. Daida, 2023, Journal of Cardiovascular Magnetic Resonance.

Impact of Low-Dose Prasugrel on Platelet Reactivity in Chronic Phase of Post-Percutaneous Coronary Intervention (CHAPERON): a Prospective Cohort Study.

H. Daida, S. Suwa, T. Dohi, 2023, Cardiovascular drugs and therapy.

Elevated levels of plasma inactive stromal cell derived factor-1α predict poor long-term outcomes in diabetic patients following percutaneous coronary intervention

T. Kasai, T. Dohi, S. Okazaki, 2024, Cardiovascular diabetology.

Long‐term impact of β‐blocker in elderly patients without myocardial infarction after percutaneous coronary intervention

H. Daida, T. Minamino, T. Dohi, 2021, ESC heart failure.

Utility of the 0-hour/1-hour high-sensitivity cardiac troponin T algorithm in Asian patients with suspected non-ST elevation myocardial infarction.

Kenji Inoue, H. Daida, Chien-Chang Lee, 2017, International journal of cardiology.

Long-term clinical outcomes and cause of death after endovascular treatment for femoropopliteal artery lesions.

H. Daida, T. Minamino, H. Iwata, 2020, Journal of cardiology.

Simultaneous Estimation of Gender Male and Atrial Fibrillation as Risk Factors for Adverse Outcomes Following Transcatheter Aortic Valve Implantation

H. Daida, T. Minamino, I. Takamisawa, 2020, Journal of clinical medicine.

Paradoxical Long-Term Impact Between Serum Apolipoprotein E and High-Density Lipoprotein Cholesterol in Patients Undergoing Percutaneous Coronary Intervention

H. Daida, T. Minamino, T. Dohi, 2022, Journal of atherosclerosis and thrombosis.

Low apolipoprotein A1 was associated with increased risk of cancer mortality in patients following percutaneous coronary intervention: A 10‐year follow‐up study

T. Minamino, T. Kasai, T. Dohi, 2022, International journal of cancer.

Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study

H. Daida, Y. Nishida, H. Iwata, 2020, Cardiovascular Diabetology.

Simultaneous subacute coronary artery stent thrombosis in a carrier of two CYP2C19 loss-of function polymorphisms (*2/*3).

Kenji Inoue, H. Iwata, I. Okai, 2016, International journal of cardiology.

Long-Term Impact of Renin-Angiotensin System Inhibitors for Secondary Prevention in Patients with Chronic Kidney Disease Who Underwent Percutaneous Coronary Intervention

T. Dohi, K. Miyauchi, S. Okazaki, 2023, Kidney Diseases.

Favorable Prognosis in Patients with Recovered Pulmonary Hypertension after TAVI: An Analysis of the LAPLACE-TAVI Registry

S. Takanashi, T. Minamino, I. Takamisawa, 2023, Journal of clinical medicine.

Dipeptidyl peptidase-4 inhibitors reduced long-term cardiovascular risk in diabetic patients after percutaneous coronary intervention via insulin-like growth factor-1 axis

T. Minamino, T. Kasai, T. Dohi, 2022, Scientific Reports.

Dipeptidyl Peptidase-4 Inhibitors Reduced Long-term Cardiovascular Risk in Japanese Diabetic Patients After Percutaneous Coronary Intervention via Insulin-like Growth Factor-1 Axis: A 10-year Follow-up Study

T. Minamino, T. Kasai, T. Dohi, 2021 .